The high Nrf2 expression in human acute myeloid leukemia is driven by NF-κB and underlies its chemo-resistance
- 20 December 2012
- journal article
- Published by American Society of Hematology in Blood
- Vol. 120 (26), 5188-5198
- https://doi.org/10.1182/blood-2012-04-422121
Abstract
NF-E2–related factor 2 (Nrf2) transcription factor regulates a range of cytoprotective transcriptional responses, preventing further cellular injury by removing biochemical damage and renewing tissue. Here we show that acute myeloid leukemia (AML) cells possess greater constitutive nuclear levels of Nrf2 than normal control CD34+ cells because of an imbalance between mRNA expression levels of Nrf2 and its inhibitor Keap1 but not through their somatic mutation. Elevated Nrf2 was reduced by NF-κB inhibitors. Using promoter assays, ChIP and siRNA knockdown, we demonstrated NF-κB subunits p50 and p65 induce transcription of Nrf2 in AML cells at a specific promoter κB-site and that long-term lentiviral miRNA-knockdown of Nrf2 significantly reduced clonogenicity of AML patient cells and improved their chemotherapeutic responsiveness. Normal physiologic Nrf2 protects cells from damage, but here we have exposed aberrant continuous nuclear activation of Nrf2 in AML that allows cell survival, even against cytotoxic chemotherapeutics. We show for the first time that Nrf2, an important regulator of several biologic processes involved in the progression of cancer, has abnormal NF-κB–driven constitutive expression in AML. Such a mechanism allows for a greater cytoprotective response in human AML cells and encourages their evasion of chemotherapy-induced cytotoxicity, which is necessary for improved clinical outcomes.Keywords
This publication has 38 references indexed in Scilit:
- Identification of novel NRF2-regulated genes by ChIP-Seq: influence on retinoid X receptor alphaNucleic Acids Research, 2012
- Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesisNature, 2011
- Common and Overlapping Oncogenic Pathways Contribute to the Evolution of Acute Myeloid LeukemiasCancer Research, 2011
- Loss of Kelch-Like ECH-Associated Protein 1 Function in Prostate Cancer Cells Causes Chemoresistance and Radioresistance and Promotes Tumor GrowthMolecular Cancer Therapeutics, 2010
- HIV-1 exploits importin 7 to maximize nuclear import of its DNA genomeRetrovirology, 2009
- ATM mediates constitutive NF-κB activation in high-risk myelodysplastic syndrome and acute myeloid leukemiaOncogene, 2008
- Nrf2- and PPARα-Mediated Regulation of Hepatic Mrp Transporters after Exposure to Perfluorooctanoic Acid and Perfluorodecanoic AcidToxicological Sciences, 2008
- Genetic disruption of the Nrf2 compromises cell-cycle progression by impairing GSH-induced redox signalingOncogene, 2008
- Impaired liver regeneration in Nrf2 knockout mice: role of ROS-mediated insulin/IGF-1 resistanceThe EMBO Journal, 2007
- Heme oxygenase-1 induction by NRF2 requires inactivation of the transcriptional repressor BACH1Nucleic Acids Research, 2007